Novo Nordisk
NVO
#33
Rank
โ‚ฌ252.67 B
Marketcap
56,77ย โ‚ฌ
Share price
-2.38%
Change (1 day)
-51.31%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): โ‚ฌ17.57 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚ฌ41.89 Billion. , an increase over its 2023 earnings that were of โ‚ฌ13.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 โ‚ฌ16.67 B22.75%
2023 โ‚ฌ13.58 B57.64%
2022 โ‚ฌ8.61 B5.35%
2021 โ‚ฌ8.17 B12.47%
2020 โ‚ฌ7.27 B13.07%
2019 โ‚ฌ6.43 B-3.35%
2018 โ‚ฌ6.65 B1.79%
2017 โ‚ฌ6.53 B4.52%
2016 โ‚ฌ6.25 B9.42%
2015 โ‚ฌ5.71 B8.24%
2014 โ‚ฌ5.28 B3.45%
2013 โ‚ฌ5.10 B19.02%
2012 โ‚ฌ4.28 B15.21%
2011 โ‚ฌ3.72 B17.71%
2010 โ‚ฌ3.16 B24.78%
2009 โ‚ฌ2.53 B10.62%
2008 โ‚ฌ2.29 B55.97%
2007 โ‚ฌ1.46 B7.07%
2006 โ‚ฌ1.37 B18.18%
2005 โ‚ฌ1.16 B11.33%
2004 โ‚ฌ1.04 B
2002 โ‚ฌ0.67 B-14.39%
2001 โ‚ฌ0.79 B-52.82%
2000 โ‚ฌ1.67 B250%
1999 โ‚ฌ0.47 B31.21%
1998 โ‚ฌ0.36 B34.31%
1997 โ‚ฌ0.27 B11.46%
1996 โ‚ฌ0.24 B9.03%
1995 โ‚ฌ0.22 B-3.15%
1994 โ‚ฌ0.23 B-0.67%
1993 โ‚ฌ0.23 B45.38%
1992 โ‚ฌ0.15 B-13.81%
1991 โ‚ฌ0.18 B37.12%
1990 โ‚ฌ0.13 B-0.79%
1989 โ‚ฌ0.13 B26.2%
1988 โ‚ฌ0.10 B24.97%
1987 โ‚ฌ86.36 M-0.9%
1986 โ‚ฌ87.14 M-7.78%
1985 โ‚ฌ94.5 M24.87%
1984 โ‚ฌ75.67 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ9.78 B-41.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.16 B-33.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ7.38 Billion-144.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.99 B-58.07%๐Ÿ‡ซ๐Ÿ‡ท France